Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 [Seeking Alpha]
Alpha Tau Medical Ltd. - Ordinary Shares (DRTS)
Company Research
Source: Seeking Alpha
Pancreatic cancer and GBM readouts expected in 2H26 have the potential to be inflection points. At ~$550M market cap, a strong cash position, and multiple upcoming readouts, DRTS offers attractive upside as it approaches proof-of-concept in high-impact oncology indications. Getty Images Overview It has been an eventful start to the year for Alpha Tau Medical ( DRTS ), which I first wrote about back in October as a unique technology/mechanism and a story set to inflect over 2026 and This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of DRTS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to wh
Show less
Read more
Impact Snapshot
Event Time:
DRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRTS alerts
High impacting Alpha Tau Medical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
DRTS
News
- Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones AheadGlobeNewswire
- Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Alpha Tau Medical (NASDAQ:DRTS) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Wall Street Breakfast Podcast: Selloff To Surge In Defense [Seeking Alpha]Seeking Alpha
- Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study [Yahoo! Finance]Yahoo! Finance
DRTS
Earnings
- 11/20/25 - Beat
DRTS
Sec Filings
- 1/29/26 - Form 6-K
- 1/14/26 - Form 144
- 1/12/26 - Form 144
- DRTS's page on the SEC website